Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells

被引:206
作者
Scadding, G. W. [1 ]
Shamji, M. H. [1 ]
Jacobson, M. R. [1 ]
Lee, D. I. [1 ]
Wilson, D. [1 ]
Lima, M. T. [1 ]
Pitkin, L. [1 ]
Pilette, C. [2 ]
Nouri-Aria, K. [1 ]
Durham, S. R. [1 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, Allergy & Clin Immunol Sect, Natl Heart & Lung Inst, Fac Med, London SW7 2AZ, England
[2] Univ Catholique Louvain, B-1348 Louvain, Belgium
基金
英国生物技术与生命科学研究理事会;
关键词
Foxp3; IgE-facilitated allergen binding; oral mucosa; specific IgG(4); sublingual immunotherapy; RANDOMIZED CONTROLLED-TRIAL; T-REGULATORY CELLS; HUMAN ORAL-MUCOSA; LANGERHANS CELLS; DENDRITIC CELLS; DOUBLE-BLIND; MAST-CELLS; RHINITIS; RHINOCONJUNCTIVITIS; VACCINATION;
D O I
10.1111/j.1365-2222.2010.03462.x
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
P>Background The mechanisms of sublingual immunotherapy (SLIT) are less well understood than those of subcutaneous immunotherapy (SCIT). Objectives To determine the effects of grass-pollen SLIT on oral mucosal immune cells, local regulatory cytokines, serum allergen-specific antibody subclasses and B cell IgE-facilitated allergen binding (IgE-FAB). Methods Biopsies from the sublingual mucosa of up to 14 SLIT-treated atopics, nine placebo-treated atopics and eight normal controls were examined for myeloid dendritic cells (mDCs) (CD1c), plasmacytoid dendritic cells (CD303), mast cells (AA1), T cells (CD3) and Foxp3 using immunofluorescence microscopy. IL-10 and TGF-beta mRNA expression were identified by in situ hybridization. Allergen-specific IgG and IgA subclasses and serum inhibitory activity for binding of allergen-IgE complexes to B cells (IgE-FAB) were measured before, during and on the completion of SLIT. Results Foxp3+ cells were increased in the oral epithelium of SLIT- vs. placebo-treated atopics (P=0.04). Greater numbers of subepithelial mDCs were present in placebo-treated, but not in SLIT-treated, atopics compared with normal controls (P=0.05). There were fewer subepithelial mast cells and greater epithelial T cells in SLIT- compared with placebo-treated atopics (P=0.1 for both). IgG(1) and IgG(4) were increased following SLIT (P < 0.001). Peak seasonal IgA(1) and IgA(2) were increased during SLIT (P < 0.05). There was a time-dependent increase in serum inhibitory activity for IgE-FAB in SLIT-treated atopics. Conclusions SLIT with grass pollen extract is associated with increased Foxp3+ cells in the sublingual epithelium and systemic humoral changes as observed previously for SCIT. Cite this as: G. W. Scadding, M. H. Shamji, M. R. Jacobson, D. I. Lee, D. Wilson, M. T. Lima, L. Pitkin, C. Pilette, K. Nouri-Aria and S. R. Durham, Clinical & Experimental Allergy, 2010 (40) 598-606.
引用
收藏
页码:598 / 606
页数:9
相关论文
共 33 条
[1]   Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? [J].
Allam, J. -P. ;
Stojanovski, G. ;
Friedrichs, N. ;
Peng, W. ;
Bieber, T. ;
Wenzel, J. ;
Novak, N. .
ALLERGY, 2008, 63 (06) :720-727
[2]   Toll-like receptor 4 ligation enforces tolerogenic properties of oral mucosal Langerhans cells [J].
Allam, Jean-Pierre ;
Peng, Wen-Ming ;
Appel, Torsten ;
Wenghoefer, Matthias ;
Niederhagen, Bernd ;
Bieber, Thomas ;
Berg, Stefaan ;
Novak, Natalija .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) :368-374
[3]   Characterization of dendritic cells from human oral mucosa:: A new Langerhans' cell type with high constitutive Fcε_RI expression [J].
Allam, JP ;
Novak, N ;
Fuchs, C ;
Asen, S ;
Bergé, S ;
Appel, T ;
Geiger, E ;
Kochan, JP ;
Bieber, T .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2003, 112 (01) :141-148
[4]   Sublingual immunotherapy induces IL-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation [J].
Bohle, Barbara ;
Kinaciyan, Tamar ;
Gerstmayr, Marianne ;
Radakovics, Astrid ;
Jahn-Schmid, Beatrice ;
Ebner, Christof .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (03) :707-713
[5]   Sublingual immunotherapy reduces allergic symptoms in a mouse model of rhinitis [J].
Brimnes, J. ;
Kildsgaard, J. ;
Jacobi, H. ;
Lund, K. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2007, 37 (04) :488-497
[6]   Characterization of CD4+CD25+ natural regulatory T cells in the inflammatory infiltrate of human chronic periodontitis [J].
Cardoso, Cristina Ribeiro ;
Garlet, Gustavo Pompermaier ;
Moreira, Ana Paula ;
Junior, Walter Martins ;
Rossi, Marcos Antonio ;
Silva, Joao Santana .
JOURNAL OF LEUKOCYTE BIOLOGY, 2008, 84 (01) :311-318
[7]   Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years [J].
Dahl, Ronald ;
Kapp, Alexander ;
Colombo, Giselda ;
De Monchy, Jan G. R. ;
Rak, Sabina ;
Emminger, Waltraud ;
Riis, Bente ;
Gronager, Pernille M. ;
Durham, Stephen R. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2008, 121 (02) :512-518
[8]   Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis [J].
Didier, Alain ;
Malling, Hans-Jorgen ;
Worm, Margitta ;
Horak, Friedrich ;
Jaeger, Siegfried ;
Montagut, Armelle ;
Andre, Claude ;
de Beaumont, Olivier ;
Melac, Michel .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 120 (06) :1338-1345
[9]   Sublingual immunotherapy with once-daily grass allergen tablets: A randomized controlled trial in seasonal allergic rhinoconjunctivitis [J].
Durham, SR ;
Yang, WH ;
Pedersen, MR ;
Johansen, N ;
Rak, S .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2006, 117 (04) :802-809
[10]   Diminished forkhead box P3/CD25 double-positive T regulatory cells are associated with the increased nuclear factor-kB ligand (RANKL+) T cells in bone resorption lesion of periodontal disease [J].
Ernst, C. W. O. ;
Lee, J. E. ;
Nakanishi, T. ;
Karimbux, N. Y. ;
Rezende, T. M. B. ;
Stashenko, P. ;
Seki, M. ;
Taubman, M. A. ;
Kawai, T. .
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2007, 148 (02) :271-280